Brachytherapy seeds work on prostate cancer:
This article was originally published in Clinica
Brachytherapy using Theragenics' radioactive seed implants performed as well as or better than traditional treatments for prostate cancer such as radical prostatectomy and external beam radiation, according to a nine-year US study. Some 83.5% of the 230 stage I and II patients treated with the company's TheraSeed - palladium 103 - implants were cancer-free at nine years, researchers from the Seattle Prostate Institute in Washington reported in the March issue of the International Journal of Radiation Oncology, Biology and Physics. Only 3% of patients experienced prostate cancer recurrence, said Theragenics of Buford, Georgia.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.